New York, NY -- (SBWIRE) -- 01/16/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Tower Semiconductor Ltd. (USA) (NASDAQ:TSEM), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), New Gold Inc. (USA) (NYSEMKT:NGD), VIVUS, Inc (NASDAQ:VVUS)
Tower Semiconductor Ltd. (USA) (NASDAQ:TSEM) showed a volume of 110.0 million shares by the end of last trade whereas the average volume of the stock remained 306,309 shares. The stock opened the session at $6.00 but then moved to $6.30. At that price, the stock showed a positive performance of 6.06%. Tower Semiconductor Ltd (Tower) is an independent specialty foundry dedicated to the manufacture of semiconductors. Tower manufactures semiconductor using production processes for its customers based on third party designs and its own designs. It offers the manufacture of integrated circuits (ICs) with geometries ranging from 1.0 to 0.13-micron.
Will TSEM Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.48 and closed the session at $3.81. The stock showed a positive performance of 5.83% in previous trading session. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, For How Long AVNR will fight for Profitability? Read This Trend Analysis report
New Gold Inc. (USA) (NYSEMKT:NGD) opened the session at $5.52 and closed the session at $5.68. The stock showed a positive performance of 0.53% in previous trading session. Traded with volume of 2.58 million shares in the prior session and the average volume of the stock remained 3.70 million shares. The beta of the stock remained 0.04. New Gold Inc. is engaged in gold mining and related activities, including acquisition, exploration, extraction, processing and reclamation. Its operating assets consist of the Mesquite gold mine (Mesquite Mine) in the United States, the Cerro San Pedro gold-silver mine (Cerro San Pedro Mine) in Mexico, and the Peak gold-copper mines in Australia.
Why Should Investors Buy NGD After The Recent Gain? Just Go Here and Find Out
VIVUS, Inc (NASDAQ:VVUS) the stock decreased -1.69% and finished the session at $9.30. Traded with volume of 2.57 million shares in the prior session and the average volume of the stock remained 1.71 million shares. The beta of the stock remained 1.31. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese),
Will VVUS Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)